DRKS00012374已完成1 期
Preclinical basic functionality testing of a new prototype lower limb exoskeleton during common locomotion tasks - XoSoft
Zürcher Hochschule für Angewandte Wissenschaften0 个研究点目标入组 20 人开始时间: 2017年4月25日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomized controlled study
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 85 Years（—）
- 性别
- All
入选标准
- •body mass index: 20-28 kg/m2
- •Mini Mental State Examination score > 24
- •Signed informed consent
- •unilateral impariment (for patients)
- •for stroke patients: main diagnosis: chronic stroke (>6 months); FAC score 3-5
- •for incomplete spinal cord injury: main diagnosis_ incomplete spinal cord injury (>6 months); FAC score 3-5
- •for frailty: 2 positive criteria for frailty phenotype, FAC score 3-5
排除标准
- •acute musculoskeletal, cardiopulmonary, neurological diseases
- •amputations
- •for patients: excessive spasticity, joint mobility restrictions in the lower limbs that interfere with daily locomotion, pain, inability to wear prototype lower limb exoskeleton
研究者
相似试验
已完成
不适用
Validation and clinical application of newly developed bioelectrical admittance method during the upper endoscopy - new underlying cause of GERDJPRN-UMIN000019518Kawasaki Medical School50
已完成
不适用
Pilot study designed to assess functionality of a low-cost negative pressure wound therapy systemISRCTN23090333Healyx Labs15
已完成
1 期
A clinical trial of influenza(H1N1) vaccine (Live attenuated) in Adults.CTRI/2010/091/000008Serum Institute of India Limited50
已完成
不适用
An early clinical feasibility study of a new prosthesis: the NewBreez® Intralaryngeal device; a possible solution for severe aspiration in head and neck cancer patientsaspirationDysfunctional larynxswallowing impairment10027656NL-OMON42228Antoni van Leeuwenhoek Ziekenhuis5
进行中（未招募）
不适用
A pilot clinical trial to evaluate the ability of pegylate r-metHg-CSF (Pegilgrastim) to accelerate haematology recovery of patients with Non-Hodgkins Lymphoma after High-dose chemiotherapy and autologous stem cell transplantation.Patients with - risk Non-Hodgkin's Lymphoma in complete or partial response who underwent autologous PBPC transplantation after high-dose chemiotherapy.MedDRA version: 6.1Level: HLTClassification code 10012819EUCTR2005-004442-14-ITIVERSITA' DEGLI STUDI DI UDINE